Tilray Inc (NASDAQ:TLRY - Get Free Report) shares shot up 3.9% during mid-day trading on Friday . The stock traded as high as $1.22 and last traded at $1.21. 9,569,517 shares traded hands during mid-day trading, a decline of 63% from the average session volume of 25,761,801 shares. The stock had previously closed at $1.16.
Wall Street Analyst Weigh In
Separately, Roth Mkm cut their price objective on shares of Tilray from $2.00 to $1.75 and set a "neutral" rating for the company in a report on Friday, October 11th.
Check Out Our Latest Research Report on TLRY
Tilray Stock Up 8.6 %
The firm's 50-day moving average price is $1.45 and its 200 day moving average price is $1.66. The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $1.14 billion, a price-to-earnings ratio of -4.67 and a beta of 2.08.
Tilray (NASDAQ:TLRY - Get Free Report) last announced its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, meeting the consensus estimate of ($0.04). The business had revenue of $200.00 million during the quarter, compared to the consensus estimate of $218.70 million. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The company's revenue was up 13.0% on a year-over-year basis. During the same period in the previous year, the business earned ($0.10) earnings per share. On average, sell-side analysts forecast that Tilray Inc will post -0.14 EPS for the current fiscal year.
Insider Buying and Selling
In related news, CFO Carl A. Merton bought 26,000 shares of the firm's stock in a transaction on Friday, November 15th. The shares were purchased at an average price of $1.36 per share, with a total value of $35,360.00. Following the completion of the purchase, the chief financial officer now owns 26,000 shares in the company, valued at $35,360. This represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. 0.87% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Tilray
Several hedge funds have recently modified their holdings of the company. Ferguson Wellman Capital Management Inc. bought a new position in Tilray in the third quarter valued at about $26,000. Signature Estate & Investment Advisors LLC acquired a new stake in Tilray during the 2nd quarter worth approximately $29,000. Jeppson Wealth Management LLC bought a new stake in Tilray during the 2nd quarter worth approximately $33,000. Vanguard Capital Wealth Advisors acquired a new position in Tilray in the 2nd quarter valued at approximately $34,000. Finally, Vista Capital Partners Inc. bought a new position in shares of Tilray during the third quarter valued at $42,000. Institutional investors and hedge funds own 9.35% of the company's stock.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Articles
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
